William Spengler - Endo International Director
Director
Mr. William F. Spengler is an Independent Director of Endo International Public Limited Company., since 2008. From November 2010 until February 2012, Mr. Spengler was President of ChromaDex Corporationrationration, a publicly traded company. From July 2008 until November 2010, Mr. Spengler served as Executive Vice President and Chief Financial Officer of Smith Wesson Holding Corporationrationration, a global leader in safety, security, protection and sport. Until March 2008, he was Executive Senior Vice President and Chief Financial Officer at MGI Pharmaceuticals Inc., an oncology and acute care focused biopharmaceutical company, where he had worked since 2005. Prior to joining MGI Pharma, Mr. Spengler was Executive Vice President and Chief Financial Officer at Guilford Pharmaceuticals Inc., a bioscience company, from July 2004 to October 2005. From 2002 to 2004, Mr. Spengler served as President, Chief Operating Officer and Director of Osteoimplant Technology, Inc., an orthopedic products company. Mr. Spengler was previously a Vice President of Finance at Black Decker, and prior to that spent 14 years in various finance, planning and business development positions at Bristol Myers Squibb. Mr. Spengler was a Director of Endo Health Solutions until February 2014. Through his senior executive roles and financial experience at various organizations, Mr. Spengler contributes expertise in financial analysis, financial statements, evaluation of business strategies, and brings to the Board valuable leadership and risk management skills. since 2008.
| Age | 60 |
| Tenure | 16 years |
| Phone | 353 1 268 2000 |
| Web | https://www.endo.com |
Endo International Management Efficiency
The company has return on total asset (ROA) of 5.11 % which means that it generated a profit of $5.11 on every $100 spent on assets. This is normal as compared to the sector avarege. Endo International's management efficiency ratios could be used to measure how well Endo International manages its routine affairs as well as how well it operates its assets and liabilities.The company currently holds 8.13 B in liabilities with Debt to Equity (D/E) ratio of 1.98, which is about average as compared to similar companies. Endo International PLC has a current ratio of 1.77, which is within standard range for the sector. Debt can assist Endo International until it has trouble settling it off, either with new capital or with free cash flow. So, Endo International's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Endo International PLC sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Endo to invest in growth at high rates of return. When we think about Endo International's use of debt, we should always consider it together with cash and equity.
Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Wesley McDonald | Wingstop | 54 | |
| Carol Lynton | El Pollo Loco | 56 | |
| Kevin Sheehan | Dave Busters Entertainment | 64 | |
| Alice Cheng | NetEase | 55 | |
| Michael Griffith | Dave Busters Entertainment | 60 | |
| Kenneth Gilbert | The Wendys Co | 67 | |
| Matthew Peltz | The Wendys Co | 35 | |
| Arthur Winkleblack | The Wendys Co | 60 | |
| Lun Feng | NetEase | 59 | |
| Dean Kehler | El Pollo Loco | 61 | |
| Luis Terminel | Meli Hotels International | 71 | |
| Kelsey Freed | The Wendys Co | N/A | |
| Samuel Borgese | El Pollo Loco | 69 | |
| Tyler Wolfram | Dave Busters Entertainment | 47 | |
| Maria Jaume | Meli Hotels International | N/A | |
| David Goebel | Wingstop | 67 | |
| Sebastian Jaume | Meli Hotels International | N/A | |
| Erik Morris | Wingstop | 39 | |
| Michelle MathewsSpradlin | The Wendys Co | 51 | |
| Michael Hislop | Wingstop | 63 | |
| Kate Lavelle | Wingstop | 52 | |
Management Performance
| Return On Equity | 0.007 | |||
| Return On Asset | 5.11 |
Endo International PLC Leadership Team
Elected by the shareholders, the Endo International's board of directors comprises two types of representatives: Endo International inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Endo. The board's role is to monitor Endo International's management team and ensure that shareholders' interests are well served. Endo International's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Endo International's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Carrie Nichol, Chief Accounting Officer, Vice President Controller | ||
| William Spengler, Director | ||
| Arthur Higgins, Independent Director | ||
| Brian Lortie, President U.S. Branded Pharmaceuticals | ||
| Donald DeGolyer, Special Advisor to the CEO | ||
| William Montague, Director | ||
| Michael Hyatt, Director | ||
| Douglas Ingram, Director | ||
| Antonio Pera, President - Par Pharmaceutical | ||
| Domenic Ciarico, Executive Vice President Chief Commercial Officer - Sterile and Generics | ||
| Roger Kimmel, Chairman of the Board | ||
| Susan Hall, Chief Scientific Officer, Global Head of RandD and Quality and Executive VP | ||
| Sharad Mansukani, Director | ||
| Suketu Upadhyay, CFO and Executive VP | ||
| Nancy Hutson, Independent Director | ||
| Todd Sisitsky, Director | ||
| Patrick Barry, Executive Vice President and Chief Commercial Officer | ||
| Shane Cooke, Independent Director | ||
| Craig Paterson, Chief Medical Officer | ||
| Daniel Rudio, Senior Vice President Chief Accounting Officer, Controller | ||
| Camille Farhat, President of American Medical Systems, Inc | ||
| Paul Campanelli, President CEO, Director | ||
| Jill Smith, Director | ||
| Rajiv Silva, CEO and President and Director | ||
| Nina Goworek, Senior Director, Investor Relations | ||
| Blaise Coleman, Senior Vice President of Global Finance Operations and Interim CFO | ||
| Terrance Coughlin, COO, Executive Vice President | ||
| Matthew Maletta, Executive Vice President Chief Legal Officer |
Endo Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Endo International a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.007 | |||
| Return On Asset | 5.11 | |||
| Profit Margin | (24.82) % | |||
| Operating Margin | 24.70 % | |||
| Current Valuation | 6.84 B | |||
| Shares Outstanding | 233.67 M | |||
| Shares Owned By Insiders | 0.79 % | |||
| Shares Owned By Institutions | 83.64 % | |||
| Number Of Shares Shorted | 41.45 M | |||
| Price To Earning | 0.37 X |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Endo International in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Endo International's short interest history, or implied volatility extrapolated from Endo International options trading.
Pair Trading with Endo International
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Endo International position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Endo International will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Western Digital could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Western Digital when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Western Digital - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Western Digital to buy it.
The correlation of Western Digital is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Western Digital moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Western Digital moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Western Digital can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment. Note that the Endo International PLC information on this page should be used as a complementary analysis to other Endo International's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Other Consideration for investing in Endo Stock
If you are still planning to invest in Endo International PLC check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Endo International's history and understand the potential risks before investing.
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |